Regression of Hepatocellular Carcinoma in Vitro and in Vivo by Radiosensitizing Suicide Gene Therapy under the Inducible and Spatial Control of Radiation-Reference-Cited by-同舟云学术

Regression of Hepatocellular Carcinoma in Vitro and in Vivo by Radiosensitizing Suicide Gene Therapy under the Inducible and Spatial Control of Radiation

Published:1999-06-10 Issue:9 Volume:10 Page:1509-1519
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Kawashita Yujo,Ohtsuru Akira,Kaneda Yasufumi,Nagayama Yuji,Kawazoe Yasushi,Eguchi Susumu,Kuroda Hiroaki,Fujioka Hikaru,Ito Masahiro,Kanematsu Takashi,Yamashita Shunichi

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/10430349950017842

Reference47 articles.

1. Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors.

2. HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS

3. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene.

4. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.

5. Hepatocellular carcinoma

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inducible caspase 9-mediated suicide gene therapy using AAV6 vectors in a murine model of breast cancer;Molecular Therapy - Methods & Clinical Development;2023-12

2. Liver‐Directed Gene Therapy;The Liver;2020-01-24

3. Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery;Advanced Materials;2019-06-20

4. Combination Suicide Gene Delivery with an Adeno-Associated Virus Vector Encoding Inducible Caspase-9 and a Chemical Inducer of Dimerization Is Effective in a Xenotransplantation Model of Hepatocellular Carcinoma;Bioconjugate Chemistry;2019-06-07

5. GRK2 overexpression inhibits IGF1-induced proliferation and migration of human hepatocellular carcinoma cells by downregulating EGR1;Oncology Reports;2016-02-26